These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6201660)

  • 1. [Methods of preparing and purifying the capsular antigen and endotoxin of the causative agent of plague].
    Veĭnblat VI; Dal'vadiants SM; Verenkov MS
    Lab Delo; 1983; (12):37-9. PubMed ID: 6201660
    [No Abstract]   [Full Text] [Related]  

  • 2. [Structural and functional properties and the biological activity of Yersinia pestis capsular antigen, murine toxin and endotoxin].
    Isin ZhM; Tugambaev TI
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Apr; (4):91-8. PubMed ID: 3300112
    [No Abstract]   [Full Text] [Related]  

  • 3. Large-scale purification of the F1 antigen of Yersinia pestis.
    Reddin KM; Easterbrook TJ; Robinson A; Williamson D; Rhind-tutt R
    Contrib Microbiol Immunol; 1995; 13():329-30. PubMed ID: 8833865
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on Yersinia antigens.
    Głośnicka R
    Bull Inst Marit Trop Med Gdynia; 1980; 31(1-2):93-5. PubMed ID: 7448457
    [No Abstract]   [Full Text] [Related]  

  • 5. [Entrapping of hydrophobized plague capsular antigen into large unilamellar liposomes].
    Zakrevskiĭ VI; Plekhanova NG; Smirnova VI
    Ukr Biokhim Zh (1978); 1989; 61(2):89-93. PubMed ID: 2728118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small protective fragments of the Yersinia pestis V antigen.
    Vernazza C; Lingard B; Flick-Smith HC; Baillie LW; Hill J; Atkins HS
    Vaccine; 2009 May; 27(21):2775-80. PubMed ID: 19366573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serovariation of the plague pathogen capsular antigen].
    Anisimov AP; Zakharova NM
    Mol Gen Mikrobiol Virusol; 1992; (9-10):26-9. PubMed ID: 1298883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new purification strategy for fraction 1 capsular antigen and its efficacy against Yersinia pestis virulent strain challenge.
    Wang T; Qi Z; Wu B; Zhu Z; Yang Y; Cui B; Dai R; Zhang Q; Qiu Y; Wang Z; Wang H; Guo Z; Wang X; Yang R
    Protein Expr Purif; 2008 Sep; 61(1):7-12. PubMed ID: 18539482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of the polysaccharide-containing somatic antigens isolated from the K-1 strain of the plague microbe and its antibiotic-resistant variants].
    Taranenko TM; Stepanov VM; Aikimbaev AM; Kovalev IF; Dernova VS
    Antibiotiki; 1978 Oct; 23(10):918-22. PubMed ID: 708003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a standardized F1 capsular antigen capture ELISA test kit for the rapid diagnosis of plague.
    Splettstoesser WD; Rahalison L; Grunow R; Neubauer H; Chanteau S
    FEMS Immunol Med Microbiol; 2004 Jun; 41(2):149-55. PubMed ID: 15145459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The biochemical aspects of the pathogenicity of the causative agent of plague].
    Naumov AV; Kuz'michenko IA; Taranenko TM; Korovkin SA; Ermakova GV
    Med Parazitol (Mosk); 1995; (4):17-22. PubMed ID: 8587511
    [No Abstract]   [Full Text] [Related]  

  • 12. [Method of preparing the tularemia antigen for an erythrocyte diagnosticum].
    Aĭkimbaev MA; Chimirov OB
    Lab Delo; 1979; (2):117-9. PubMed ID: 85742
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression of Yersinia pestis V antigen in attenuated salmonella typhimurium: development of a novel vaccine for plague.
    Leary SE; Eley SM; Williamson ED; Titball RW
    Contrib Microbiol Immunol; 1995; 13():216-7. PubMed ID: 8833838
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of Yersinia pestis antigens and strains on the level of lymphocyte blast transformation].
    Ledvanov MIu; Emel'ianova NV; Stukova NIu; Shvedun GP; Taranenko TM; Brandzishevskiĭ IuV
    Med Parazitol (Mosk); 1998; (4):25-7. PubMed ID: 10050549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A rapid diagnostic test for plague detects Yersinia pestis F1 antigen in ancient human remains].
    Bianucci R; Rahalison L; Ferroglio E; Massa ER; Signoli M
    C R Biol; 2007 Oct; 330(10):747-54. PubMed ID: 17905394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.
    Glynn A; Roy CJ; Powell BS; Adamovicz JJ; Freytag LC; Clements JD
    Infect Immun; 2005 Aug; 73(8):5256-61. PubMed ID: 16041052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Method of obtaining a Y. pestis fraction containing heterogenetic antigens].
    Bochko GM; Nekliaev VN; Efremenko VI
    Lab Delo; 1979; (9):554-5. PubMed ID: 91715
    [No Abstract]   [Full Text] [Related]  

  • 19. [Some features of action of "murine" toxin and Yersinia pestis antigen fraction I in cells sensitive to animal plague].
    Aseeva LE; Mishan'kin MB; Goncharov EK; Shevchenko LA
    Biull Eksp Biol Med; 1995 Feb; 119(2):193-5. PubMed ID: 7670051
    [No Abstract]   [Full Text] [Related]  

  • 20. The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague.
    Derewenda U; Mateja A; Devedjiev Y; Routzahn KM; Evdokimov AG; Derewenda ZS; Waugh DS
    Structure; 2004 Feb; 12(2):301-6. PubMed ID: 14962390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.